Westwood, KSNCT07174453Now EnrollingIRB Ready

Solid Tumor Malignancies Clinical Trial in Westwood, KS

Access cutting-edge solid tumor malignancies treatment through this clinical trial at a research site in Westwood. Study-provided care at no cost to qualified participants.

Sponsored by University of Kansas Medical Center

Quick Self-Assessment

See if you qualify for this Westwood location

Preparing your pre-screening questions…

Expert Care in Westwood

Access solid tumor malignancies specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related solid tumor malignancies treatment provided free

Apply for This Westwood Location

Check if you qualify for this solid tumor malignancies clinical trial in Westwood, KS

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Westwood

    Convenient for KS residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Westwood site if eligible
  4. 4Begin participation

About This Solid Tumor Malignancies Study in Westwood

Phase 3/4 open label, randomized two cohort study (2 arms in each cohort). It is hypothesized that for people with a histologically or cytologically confirmed diagnosis of malignancy, the higher dose immunotherapy (every 6 weeks Pembrolizumab 400mg dose and every 4 weeks Nivolumab 480mg dose) has more immune-related adverse events irAEs compared to lower dose (every 3 weeks Pembrolizumab 200mg dose and every 2 weeks Nivolumab 240mg dose).

Sponsor: University of Kansas Medical Center

Who Can Participate

Inclusion Criteria

Ability of participant to understand this study, and participant willingness to sign a written informed consent.
Males and females age ≥ 18 years
ECOG Performance Status (PS) 0 - 2 (Appendix A.)
Females of childbearing potential must have a negative urine pregnancy test 72 hours prior to initiating treatment.
Histologically or cytologically confirmed diagnosis of solid tumor malignancy
Eligible to receive pembrolizumab or nivolumab based therapy
Any disease setting (neoadjuvant, adjuvant, unresectable, metastatic) or any line of therapy is allowed. NOTE: Standard of care combination agents(chemotherapy, targeted therapy, biologics) are allowed because irAEs are the primary objective
Adequate organ function, defined as follows: Leukocytes (White Blood Cell \[WBC\]) \>1.0 K/UL Absolute Neutrophil Count \>1.0 K/UL Platelets \> 50 K/UL Hemoglobin ≥ 7 g/dL Serum creatinine ≤ 1.5 x upper limit of normal (ULN) or calculated creatinine clearance ≥ 50 mL/min using the Cockcroft-Gault equation Total bilirubin ≤ 1.5 x ULN Aspartate aminotransferase and alanine aminotransferase ≤ 2.5 x ULN unless liver metastases are present, in which case they must be ≤ 5 x ULN

Exclusion Criteria

Simultaneously enrolled in any therapeutic clinical trial
Concurrent or planned use of other immunotherapies or radiation
Has not recovered from irAEs due to prior immunotherapy treatment (\>=grade 2 is considered not recovered). Conditions that meet grade 2 criteria but are considered clinically stable at the discretion of the investigator will be allowed.
Diagnosed with a psychiatric illness or is in a social situation that would limit compliance with study requirements
Currently pregnant or breastfeeding
Has a known allergic reaction to any excipient contained in the study drug formulation
Active Grade 3 (per the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE), Version 5.0 ) or higher viral, bacterial, or fungal infection within 2 weeks prior to the first dose of study treatment.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Westwood?

Yes, this clinical trial (NCT07174453) has an active research site in Westwood, KS that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Solid Tumor Malignancies Treatment Options in Westwood, KS

If you're searching for solid tumor malignancies treatment options in Westwood, KS, this clinical trial (NCT07174453) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Westwood research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumor malignancies specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all solid tumor malignancies clinical trials near you to find additional studies recruiting in your area.

More Advanced Solid Tumors Trials in Westwood, KS

See all advanced solid tumors clinical trials recruiting in Westwood — not just this study.

Browse Advanced Solid Tumors Trials in Westwood →

Browse More Trials by Condition

Advanced Solid Tumors TrialsAll Conditions →

Ready to Join in Westwood?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Westwood, KS